On May 13, 2025, JMP Securities analyst Constantine Davides has announced an updated target price for OptimizeRx (OPRX, Financial), a prominent player in the healthcare communication solutions sector. The new target price has been raised from USD 11.00 to USD 14.00, marking a 27.27% increase.
The rating for OptimizeRx (OPRX, Financial) has been maintained at "Market Outperform," reflecting positive sentiment towards the company's future market performance. This reaffirmation of the rating suggests confidence in OptimizeRx's continued growth and advancement in its industry niche.
The consistent "Market Outperform" rating by JMP Securities underscores the analyst's anticipation of OptimizeRx (OPRX, Financial) stock outperforming its peers and the broader market. Investors and stakeholders are advised to monitor the company's progress closely in the light of this updated outlook.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 7 analysts, the average target price for OptimizeRx Corp (OPRX, Financial) is $11.04 with a high estimate of $16.00 and a low estimate of $6.00. The average target implies an upside of 0.87% from the current price of $10.94. More detailed estimate data can be found on the OptimizeRx Corp (OPRX) Forecast page.
Based on the consensus recommendation from 7 brokerage firms, OptimizeRx Corp's (OPRX, Financial) average brokerage recommendation is currently 1.9, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for OptimizeRx Corp (OPRX, Financial) in one year is $22.28, suggesting a upside of 103.66% from the current price of $10.94. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the OptimizeRx Corp (OPRX) Summary page.
